RxDoctor Payments Data

Stephanie Meyers

Nurse Practitioner · Houston, TXNPI 1457797607

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Astellas Pharma US Inc accounts for 69.4% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $5,698 and has fallen 99.6% since, to $21 in 2025. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,362in general payments, 2019–2025

Across 114 payments — averaging $64.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$5K
  • AbbVie$469
  • Evofem Biosciences, Inc.$230
  • Myovant Sciences Inc.$184
  • Mayne Pharma Commercial LLC$179
  • Pfizer$145
  • plus $1K from 21 others

What the payments were for

  • Consulting fees$3,48647%
  • Travel & lodging$92913%
  • Food & beverage$2,84739%
  • Education$1001%

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,362 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.

See all nurse practitioner providers in Texas →

Other nurse practitioner in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →